Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform
SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page